Research programme: hormone-sensitive lipase inhibitors - Novo NordiskAlternative Names: 76-0079; Hormone-sensitive lipase inhibitors research programme - Novo Nordisk; HSL inhibitors - Novo Nordisk
Latest Information Update: 24 Feb 2011
At a glance
- Originator Novo Nordisk
- Class Boronic acids; Triazoles
- Mechanism of Action Sterol esterase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Diabetes mellitus
Most Recent Events
- 07 Sep 2004 Preclinical trials in Diabetes mellitus in Denmark (unspecified route)